The Brown lab at Harvard Medical School focuses on understanding how tiny structures called cilia and flagella function in various organisms, including humans and parasites. Their research explores the molecular mechanisms that control the movement of these structures, which play crucial roles in processes like fertility and disease. By using cutting-edge techniques, they hope to uncover how these movements are regulated and how this knowledge can lead to new treatments for diseases caused by parasites that affect millions of people.

Stephen Buratowski's lab at Harvard Medical School focuses on understanding the intricate processes of gene expression by examining how RNA polymerase II, an enzyme responsible for transcribing DNA into RNA, is regulated. The lab investigates the role of various protein modifications and interactions during transcription, which has significant implications for diseases such as cancer and viral infections like HIV. By utilizing cutting-edge techniques like mass spectrometry and single-molecule microscopy, they aim to uncover dynamic events that govern gene expression, potentially leading to new therapeutic strategies.

Dr. Stephen C. Blacklow's lab at Harvard Medical School focuses on understanding the molecular mechanisms of cellular signaling, particularly through Notch signaling and tetraspanin proteins. They employ advanced technologies to visualize how signals are transmitted within cells, which is important for understanding diseases like cancer and immune disorders. The lab's research aims to pave the way for future therapeutic strategies by elucidating the roles of these signaling pathways in both normal physiology and disease states.

Dr. Joseph J. Loparo's research lab at Harvard Medical School focuses on understanding how cells repair damaged DNA, specifically through a process called non-homologous end joining (NHEJ). This repair mechanism is crucial for maintaining genomic integrity, and understanding it can have implications for cancer treatment and gene therapy. By using advanced imaging techniques, the lab investigates the molecular details of how DNA ends are fixed and how errors can occur during this process, leading to potential diseases.

Dr. Andrew Kruse's lab at Harvard Medical School focuses on understanding the molecular mechanisms behind bacterial cell wall synthesis. They study essential enzymes responsible for creating and maintaining the cell wall, which are potential targets for new antibiotics. By using advanced techniques in structural biology and single-molecule fluorescence, the lab aims to uncover how these enzymes are activated and regulated, paving the way for antibiotic development.

Dr. Kevin Struhl's lab at Harvard Medical School focuses on understanding how genes are expressed in eukaryotic organisms, linking these mechanisms to human diseases. The research primarily investigates the processes of mRNA production, stability, and how specific RNA sequences affect gene regulation. Through innovative experiments and techniques, the lab aims to uncover the fundamental roles of transcription and mRNA processing in genetics and biological function.

Dr. Abigail Sloan Devlin's lab at Harvard Medical School focuses on understanding the role of microbiome-derived sulfated metabolites in human health. Their research investigates how these compounds, produced by gut bacteria, can influence immune responses and potentially lead to new therapies for diseases like autoimmune disorders. By combining analytical chemistry and biological studies, the lab aims to uncover the identity and function of these metabolites and the bacteria that produce them.

Dr. Karen L. Adelman's lab at Harvard Medical School focuses on understanding how the Integrator complex regulates gene expression in response to various signals. This work is crucial for deciphering mechanisms underlying normal development and diseases that arise from dysfunctions in these processes, such as cancer and developmental disorders. The research provides insights into how cells respond to stress and environmental cues by controlling the production of messenger RNA.